| Sung Ho Lee, MD | |
|
160 N Midland Ave, Nyack, NY 10960-1912 | |
| (845) 480-7440 | |
| (845) 480-7448 |
| Full Name | Sung Ho Lee |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 24 Years |
| Location | 160 N Midland Ave, Nyack, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841426780 | NPI | - | NPPES |
| 03628140 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 270831 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nyack Hospital | Nyack, NY | Hospital |
| Good Samaritan Hospital Of Suffern | Suffern, NY | Hospital |
| Helen Hayes Hospital | West haverstraw, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| White Plains Medical Diagnostic Services, Pc | 5395918932 | 66 |
News Archive
A new report from a team of health care CEOs and researchers says California could save $110 billion over a decade if the state moved away from "fee-for-service" payment to doctors and into more coordinated care.
Laboratory Corporation of America Holdings announced today the nationwide availability of a new FDA cleared risk stratification tool (ROMA, Risk of Ovarian Malignancy Algorithm) that combines the results for Fujirebio HE4, Abbott's ARCHITECT CA 125 II, and menopausal status into a numerical score that, along with clinical and radiological evaluation, can aid in evaluating whether a woman over the age of 18 who presents with an ovarian mass and for whom surgery is planned is at high or low likelihood of finding malignancy on surgery.
A team at Scripps Research in Florida has discovered a biological system that manages cells' response to opioid drug exposure. The unexpected discovery offers new ideas for improving the safety of the one of the most effective, and most abused, group of pain medications.
Results of Eastern Cooperative Oncology Group Phase III clinical trial E4A03, for multiple myeloma, showing significantly better overall survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone, were reported today by S. Vincent Rajkumar, M.D. at the American Society of Hematology's annual meeting.
› Verified 3 days ago
| Entity Name | Highland Medical P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376600304 PECOS PAC ID: 2668370420 Enrollment ID: O20031230000737 |
News Archive
A new report from a team of health care CEOs and researchers says California could save $110 billion over a decade if the state moved away from "fee-for-service" payment to doctors and into more coordinated care.
Laboratory Corporation of America Holdings announced today the nationwide availability of a new FDA cleared risk stratification tool (ROMA, Risk of Ovarian Malignancy Algorithm) that combines the results for Fujirebio HE4, Abbott's ARCHITECT CA 125 II, and menopausal status into a numerical score that, along with clinical and radiological evaluation, can aid in evaluating whether a woman over the age of 18 who presents with an ovarian mass and for whom surgery is planned is at high or low likelihood of finding malignancy on surgery.
A team at Scripps Research in Florida has discovered a biological system that manages cells' response to opioid drug exposure. The unexpected discovery offers new ideas for improving the safety of the one of the most effective, and most abused, group of pain medications.
Results of Eastern Cooperative Oncology Group Phase III clinical trial E4A03, for multiple myeloma, showing significantly better overall survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone, were reported today by S. Vincent Rajkumar, M.D. at the American Society of Hematology's annual meeting.
› Verified 3 days ago
| Entity Name | White Plains Medical Diagnostic Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689955338 PECOS PAC ID: 5395918932 Enrollment ID: O20111027000238 |
News Archive
A new report from a team of health care CEOs and researchers says California could save $110 billion over a decade if the state moved away from "fee-for-service" payment to doctors and into more coordinated care.
Laboratory Corporation of America Holdings announced today the nationwide availability of a new FDA cleared risk stratification tool (ROMA, Risk of Ovarian Malignancy Algorithm) that combines the results for Fujirebio HE4, Abbott's ARCHITECT CA 125 II, and menopausal status into a numerical score that, along with clinical and radiological evaluation, can aid in evaluating whether a woman over the age of 18 who presents with an ovarian mass and for whom surgery is planned is at high or low likelihood of finding malignancy on surgery.
A team at Scripps Research in Florida has discovered a biological system that manages cells' response to opioid drug exposure. The unexpected discovery offers new ideas for improving the safety of the one of the most effective, and most abused, group of pain medications.
Results of Eastern Cooperative Oncology Group Phase III clinical trial E4A03, for multiple myeloma, showing significantly better overall survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone, were reported today by S. Vincent Rajkumar, M.D. at the American Society of Hematology's annual meeting.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sung Ho Lee, MD 160 N Midland Ave, Nyack, NY 10960-1912 Ph: (845) 480-7440 | Sung Ho Lee, MD 160 N Midland Ave, Nyack, NY 10960-1912 Ph: (845) 480-7440 |
News Archive
A new report from a team of health care CEOs and researchers says California could save $110 billion over a decade if the state moved away from "fee-for-service" payment to doctors and into more coordinated care.
Laboratory Corporation of America Holdings announced today the nationwide availability of a new FDA cleared risk stratification tool (ROMA, Risk of Ovarian Malignancy Algorithm) that combines the results for Fujirebio HE4, Abbott's ARCHITECT CA 125 II, and menopausal status into a numerical score that, along with clinical and radiological evaluation, can aid in evaluating whether a woman over the age of 18 who presents with an ovarian mass and for whom surgery is planned is at high or low likelihood of finding malignancy on surgery.
A team at Scripps Research in Florida has discovered a biological system that manages cells' response to opioid drug exposure. The unexpected discovery offers new ideas for improving the safety of the one of the most effective, and most abused, group of pain medications.
Results of Eastern Cooperative Oncology Group Phase III clinical trial E4A03, for multiple myeloma, showing significantly better overall survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone, were reported today by S. Vincent Rajkumar, M.D. at the American Society of Hematology's annual meeting.
› Verified 3 days ago
Pamela Charney, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 160 N Midland Ave, Adult Hospital Medicine, Nyack Hospital, Nyack, NY 10960 Phone: 845-348-2000 | |
Gerald Abraham Ancheta, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 311 N Midland Ave, Nyack, NY 10960 Phone: 845-358-5006 Fax: 845-358-4340 | |
Dr. Azfar Chak, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 311 N Midland Ave, Nyack, NY 10960 Phone: 845-358-5006 Fax: 845-358-4340 | |
Dr. Boris Melnikau, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 160 N Midland Ave, Nyack, NY 10960 Phone: 845-348-8884 | |
Mr. Jayesh Sampat, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 160 N Midland Ave, Nyack, NY 10960 Phone: 845-348-2000 | |
Mr. Raphael Flowers, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 160 N Midland Ave, Nyack, NY 10960 Phone: 845-348-2000 | |
Smitha Karuthedom, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 160 N Midland Ave, Nyack, NY 10960 Phone: 845-348-2000 |